Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (60)
Shimeng Liang, Xiaoqin Liu, Jia Liu, Feifei Na, Jialu Lai, Leiya Du, Youling Gong, Jiang Zhu, Meijuan Huang, Xiaojuan Zhou, Yong Xu & Lin Zhou. (2023) Optimal timing of hypofractionated stereotactic radiotherapy for epidermal growth factor receptor‐mutated non‐small‐cell lung cancer patients with brain metastases. Asia-Pacific Journal of Clinical Oncology 19:6, pages 731-738.
Crossref
Crossref
Caroline Beverley Dobeson, Matthew Birkbeck, Priya Bhatnagar, Julie Hall, Rachel Pearson, Serena West, Philip English, David Butteriss, Joanna Perthen & Joanne Lewis. (2023) Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X). The British Journal of Radiology.
Crossref
Crossref
Andrea Romano, Giulia Moltoni, Antonella Blandino, Serena Palizzi, Allegra Romano, Giulia de Rosa, Lara De Blasi Palma, Cristiana Monopoli, Alessia Guarnera, Giuseppe Minniti & Alessandro Bozzao. (2023) Radiosurgery for Brain Metastases: Challenges in Imaging Interpretation after Treatment. Cancers 15:20, pages 5092.
Crossref
Crossref
Isabelle Chambrelant, Delphine Jarnet, Jolie Bou-Gharios, Clara Le Fèvre, Laure Kuntz, Delphine Antoni, Catherine Jenny & Georges Noël. (2023) Stereotactic Radiation Therapy of Single Brain Metastases: A Literature Review of Dosimetric Studies. Cancers 15:15, pages 3937.
Crossref
Crossref
Benoît Calderon, Léa Vazquez, Mohammed Belkacemi & Nicolas Pourel. (2023) Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis. European Journal of Medical Research 28:1.
Crossref
Crossref
J. A. Crouzen, A. L. Petoukhova, M. L. D. Broekman, M. Fiocco, U. J. Fisscher, J. H. Franssen, C. G. M. Gadellaa-van Hooijdonk, M. Kerkhof, M. Kiderlen, M. E. Mast, C. M. van Rij, R. Nandoe Tewarie, M. A. E. van de Sande, P. P. G. van der Toorn, R. Vlasman, M. J. Vos, N. C. M. G. van der Voort van Zyp, R. G. J. Wiggenraad, L. M. Wiltink & J. D. Zindler. (2023) SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases. BMC Cancer 23:1.
Crossref
Crossref
Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler & Michael C. Repka. (2023) Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure. Frontiers in Oncology 13.
Crossref
Crossref
Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Davide Fiorentin, Davide Bimbatti, Umberto Basso & Fabio Busato. (2023) Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature. Frontiers in Oncology 13.
Crossref
Crossref
Katharina Hintelmann, Cordula Petersen & Kerstin Borgmann. (2022) Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells. Cancers 15:1, pages 211.
Crossref
Crossref
Sandrine Pereira, Ester Orlandi, Sophie Deneuve, Amelia Barcellini, Agnieszka Chalaszczyk, Isabelle Behm-Ansmant, Liza Hettal, Tiziana Rancati, Guillaume Vogin & Juliette Thariat. (2022) The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review. Cancers 14:24, pages 6252.
Crossref
Crossref
Lili Yang, Congxiao Wang, Wei Zhang, Shifeng Liu, Tiantian Xuan, Han Jiang, Xiaokun Hu, Man Hu & Huanting Li. (2022) Iodine-125 brachytherapy treatment for newly diagnosed brain metastasis in non-small cell lung cancer: A biocentric analysis. Frontiers in Oncology 12.
Crossref
Crossref
Klaus-Henning Kahl, Ehab Shiban, Susanne Gutser, Christoph J. Maurer, Björn Sommer, Heiko Müller, Ina Konietzko, Ute Grossert, Ansgar Berlis, Tilman Janzen & Georg Stüben. (2022) Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control. Strahlentherapie und Onkologie 198:12, pages 1105-1111.
Crossref
Crossref
Brice Leyrat, Toufic Khalill, Jean-Jacques Lemaire, Melanie Casile, Ioana Molnar, Véronique Dedieu, Vincent Chassin, Guillaume Dupic, Aurélie Bellière, Xavier Durando, Michel Lapeyre, Pierre Verrelle & Julian Biau. (2022) Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors. Clinical and Translational Radiation Oncology 36, pages 1-8.
Crossref
Crossref
Marcus Unterrainer, Adrien Holzgreve, Bogdana Suchorska & Nathalie L. Albert. 2022. Clinical Nuclear Medicine in Neurology. Clinical Nuclear Medicine in Neurology
159
161
.
Matthew N. Mills, Chelsea Walker, Chetna Thawani, Afrin Naz, Nicholas B. Figura, Sergiy Kushchayev, Arnold Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han & Kamran A. Ahmed. (2021) Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases. BMC Cancer 21:1.
Crossref
Crossref
Nuria Mederos, Jeremy Jankovic, Ruth Gabriela Herrera Gomez, Vincent Dunet & Valerie Cristina. (2021) Intracranial response to a combination of bevacizumab and epirubicin for an adenoid cystic carcinoma of the external auditory canal: A case report and review of the literature. Current Problems in Cancer: Case Reports 4, pages 100130.
Crossref
Crossref
Lauritz Miarka & Manuel Valiente. (2021) Animal models of brain metastasis. Neuro-Oncology Advances 3:Supplement_5, pages v144-v156.
Crossref
Crossref
Lucia Nichelli & Stefano Casagranda. (2021) Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis. Current Opinion in Oncology 33:6, pages 597-607.
Crossref
Crossref
Kamran A. Ahmed, Youngchul Kim, John A. Arrington, Sungjune Kim, Michelle DeJesus, Aixa E. Soyano, Avan J. Armaghani, Ricardo L.B. Costa, Hung T. Khong, Loretta S. Loftus, Marilin Rosa, Jimmy J. Caudell, Roberto Diaz, Timothy J. Robinson, Arnold B. Etame, Nam D. Tran, Solmaz Sahebjam, Hatem H. Soliman, Brian J. Czerniecki, Peter A. Forsyth, H. Michael Yu & Hyo S. Han. (2021) Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study. Advances in Radiation Oncology 6:6, pages 100798.
Crossref
Crossref
Johannes Kerschbaumer, Matthias Demetz, Aleksandrs Krigers, Meinhard Nevinny-Stickel, Claudius Thomé & Christian F. Freyschlag. (2021) Risk Factors for Radiation Necrosis in Patients Undergoing Cranial Stereotactic Radiosurgery. Cancers 13:19, pages 4736.
Crossref
Crossref
Yuxiang Weng, Jie Shen, Luyuan Zhang, Zebin Fang, Feng Xiao, Chao Zhang, Zuoxu Fan, Kaiyuan Huang, Liyun Wang, Bin Huang, Fan Wu, Tiesong Zhang & Qingsheng Xu. (2021) Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases. Frontiers in Surgery 8.
Crossref
Crossref
Assaf Moore, Shlomit Yust-Katz, Oded Icht, Ruth Eliyahou, Noa Gordon, Aharon Yehonatan Cohen, Iris Magdalena Goldstein, Nir Peled, Tali Seigal, Alexandra Amiel & Elizabeth Dudnik. (2021) Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. Journal of the Neurological Sciences 427, pages 117556.
Crossref
Crossref
Ranjan Pathak, Arya Amini, Addie Hill, Erminia Massarelli & Ravi Salgia. (2021) Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions. Cancers 13:14, pages 3407.
Crossref
Crossref
Francesco Cicone, Luciano Carideo, Claudia Scaringi, Andrea Romano, Marcelo Mamede, Annalisa Papa, Anna Tofani, Giuseppe Lucio Cascini, Alessandro Bozzao, Francesco Scopinaro & Giuseppe Minniti. (2021) Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET. Neuro-Oncology 23:6, pages 1024-1034.
Crossref
Crossref
Casey W. Williamson, Michael V. Sherer, Dmitriy Zamarin, Andrew B. Sharabi, Brandon A. Dyer, Loren K. Mell & Jyoti S. Mayadev. (2021) Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety. Cancer 127:10, pages 1553-1567.
Crossref
Crossref
L. Brun, G. Dupic, V. Chassin, E. Chautard, J. Moreau, V. Dedieu, T. Khalil, P. Verrelle, M. Lapeyre & J. Biau. (2021) Hypofractionated stereotactic radiotherapy for large brain metastases: Optimizing the dosimetric parameters. Cancer/Radiothérapie 25:1, pages 1-7.
Crossref
Crossref
Yae Won ParkNarae LeeSung Soo AhnJong Hee ChangSeung-Koo Lee. (2021) Radiomics and Deep Learning in Brain Metastases: Current Trends and Roadmap to Future Applications. Investigative Magnetic Resonance Imaging 25:4, pages 266.
Crossref
Crossref
Eva Elisabeth van Grinsven, Steven H.J. Nagtegaal, Joost J.C. Verhoeff & Martine J.E. van Zandvoort. (2021) The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis. Oncology Research and Treatment 44:11, pages 622-636.
Crossref
Crossref
Guillaume Vogin. 2021. Survivorship Care for Cancer Patients. Survivorship Care for Cancer Patients
257
285
.
Laurence Mengue, Aurélie Bertaut, Louise Ngo Mbus, Mélanie Doré, Myriam Ayadi, Karen Clément-Colmou, Line Claude, Christian Carrie, Cécile Laude, Ronan Tanguy, Julie Blanc & Marie-Pierre Sunyach. (2020) Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation. Radiation Oncology 15:1.
Crossref
Crossref
Johanna S. Ziegler, Stephanie Kroeze, Marie-Luise Hilbers, Laurence Imhof, Matthias Guckenberger, Mitchell P. Levesque, Reinhard Dummer, Phil Cheng & Joanna Mangana. (2020) Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis. Melanoma Research 30:6, pages 552-561.
Crossref
Crossref
Ozge Petek Erpolat, Niyazi Volkan Demircan, Gulistan Sanem Sarıbas, Pelin Kuzucu, Ertugrul Senturk, Cigdem Elmas, Alp Borcek & Gokhan Kurt. (2020) A Comparison of Ramipril and Bevacizumab to Mitigate Radiation-Induced Brain Necrosis: An Experimental Study. World Neurosurgery 144, pages e210-e220.
Crossref
Crossref
Ralf Gutzmer, Dirk Vordermark, Jessica C. Hassel, Dietmar Krex, Christina Wendl, Dirk Schadendorf, Thomas Sickmann, Stefan Rieken, Tobias Pukrop, Christoph Höller, Thomas K. Eigentler & Friedegund Meier. (2020) Melanoma brain metastases – Interdisciplinary management recommendations 2020. Cancer Treatment Reviews 89, pages 102083.
Crossref
Crossref
Marco Lupattelli, Emanuele Alì, Gianluca Ingrosso, Simonetta Saldi, Christian Fulcheri, Simona Borghesi, Roberto Tarducci & Cynthia Aristei. (2020) Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis. Journal of Personalized Medicine 10:3, pages 59.
Crossref
Crossref
David Bergman, Ankit Modh, Lonni Schultz, James Snyder, Tom Mikkelsen, Mira Shah, Samuel Ryu, M. Salim Siddiqui & Tobias Walbert. (2020) Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma. Journal of Neuro-Oncology 148:2, pages 353-361.
Crossref
Crossref
J. Travis Mendel, Adam W. Jaster, Fang F. YuLee C. MorrisIIIIII, Patrick T. Lynch, Bhavya R. ShahAmit Agarwal, Robert D. TimmermanLucien A. NedziKaruna M. Raj. (2020) Fundamentals of Radiation Oncology for Neurologic Imaging. RadioGraphics 40:3, pages 827-858.
Crossref
Crossref
Liza Hettal, Anais Stefani, Julia Salleron, Florent Courrech, Isabelle Behm-Ansmant, Jean Marc Constans, Guillaume Gauchotte & Guillaume Vogin. (2020) Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis. Radiation Research 193:5, pages 471.
Crossref
Crossref
L. Kuntz, R. Matthis, N. Wegner & S. Lutz. (2020) Dosimetric comparison of mono-isocentric and multi-isocentric plans for oligobrain metastases: A single institutional experience. Cancer/Radiothérapie 24:1, pages 53-59.
Crossref
Crossref
Orit Kaidar-Person, Michael Cools & Timothy Zagar. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
794
808.e3
.
Frédéric Dhermain. 2020. Central Nervous System Metastases. Central Nervous System Metastases
239
245
.
Priscilla K. Stumpf, Diana M. Cittelly, Tyler P. Robin, Julie A. Carlson, Kelly A. Stuhr, Maria Jose Contreras-Zarate, Steven Lai, D. Ryan Ormond, Chad G. Rusthoven, Laurie E. Gaspar, Rachel Rabinovitch, Brian D. Kavanagh, Arthur Liu, Jennifer R. Diamond, Peter Kabos & Christine M. Fisher. (2019) Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clinical Cancer Research 25:13, pages 3946-3953.
Crossref
Crossref
Zeynep Eroglu, Sheri L. Holmen, Qing Chen, Nikhil I. Khushalani, Ravi Amaravadi, Reena Thomas, Kamran A. Ahmed, Hussein Tawbi, Sunandana Chandra, Joseph Markowitz, Inna Smalley, James K. C. Liu, Yian Ann Chen, Yana G. Najjar, Florian A. Karreth, Daniel Abate‐Daga, Isabella C. Glitza, Jeffrey A. Sosman, Vernon K. Sondak, Marcus Bosenberg, Meenhard Herlyn, Michael B. Atkins, Harriet Kluger, Kim Margolin, Peter A. Forsyth, Michael A. Davies & Keiran S. M. Smalley. (2019) Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell & Melanoma Research 32:3, pages 458-469.
Crossref
Crossref
Michael A. Izard, Vaughan Moutrie, Jeffrey M. Rogers, Ken Beath, Michael Grace, Bianca Karle, Annie Ho & John W. Fuller. (2019) Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective. Radiotherapy and Oncology 133, pages 43-49.
Crossref
Crossref
Eric J. Lehrer, Jennifer L. Peterson, Nicholas G. Zaorsky, Paul D. Brown, Arjun Sahgal, Veronica L. Chiang, Samuel T. Chao, Jason P. Sheehan & Daniel M. Trifiletti. (2019) Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials. International Journal of Radiation Oncology*Biology*Physics 103:3, pages 618-630.
Crossref
Crossref
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, Dirk Daubner, Fabian Lohaus, Lisa Zimmer, Andrea Forschner, Daniel Zips, Jessica C. Hassel, Carola Berking, Katharina C. Kaehler, Jochen Utikal, Ralf Gutzmer, Patrik Terheyden, Frank Meiss, David Rafei-Shamsabadi, Felix Kiecker, Dirk Debus, Evelyn Dabrowski, Andreas Arnold, Marlene Garzarolli, Marvin Kuske, Stefan Beissert, Steffen Löck, Jennifer Linn, Esther G.C. Troost & Friedegund Meier. (2019) Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases. European Journal of Cancer 110, pages 11-20.
Crossref
Crossref
Gokoulakrichenane Loganadane, Frédéric Dhermain, Guillaume Louvel, Paul Kauv, Eric Deutsch, Cécile Le Péchoux & Antonin Levy. (2018) Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients. Frontiers in Oncology 8.
Crossref
Crossref
Marvin Kuske, Ricarda Rauschenberg, Marlene Garzarolli, Michelle Meredyth-Stewart, Stefan Beissert, Esther G. C. Troost, Oliva Isabella Claudia Glitza & Friedegund Meier. (2018) Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges. American Journal of Clinical Dermatology 19:4, pages 529-541.
Crossref
Crossref
Dianne Hartgerink, Britt van der Heijden, Dirk De Ruysscher, Alida Postma, Linda Ackermans, Ann Hoeben, Monique Anten, Philippe Lambin, Karin Terhaag, Arthur Jochems, Andre Dekker, Janna Schoenmaekers, Lizza Hendriks & Jaap Zindler. (2018) Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions. Frontiers in Oncology 8.
Crossref
Crossref
Odelin Charron, Alex Lallement, Delphine Jarnet, Vincent Noblet, Jean-Baptiste Clavier & Philippe Meyer. (2018) Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network. Computers in Biology and Medicine 95, pages 43-54.
Crossref
Crossref
Leonardo Rundo, Carmelo Militello, Andrea Tangherloni, Giorgio Russo, Salvatore Vitabile, Maria Carla Gilardi & Giancarlo Mauri. (2018) NeXt for neuro-radiosurgery: A fully automatic approach for necrosis extraction in brain tumor MRI using an unsupervised machine learning technique. International Journal of Imaging Systems and Technology 28:1, pages 21-37.
Crossref
Crossref
Alexandra Hellerbach, Klaus Luyken, Mauritius Hoevels, Andreas Gierich, Daniel Rueß, Wolfgang W. Baus, Martin Kocher, Maximilian I. Ruge & Harald Treuer. (2017) Radiotoxicity in robotic radiosurgery: proposing a new quality index for optimizing the treatment planning of brain metastases. Radiation Oncology 12:1.
Crossref
Crossref
Isabella C. Glitza, Nandita Guha-Thakurta, Neil M. D’Souza, Rodabe N. Amaria, Susan L. McGovern, Ganesh Rao & Jing Li. (2017) Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Melanoma Research 27:6, pages 580-584.
Crossref
Crossref
Alexandra K. Ciminera, Rahul Jandial & John Termini. (2017) Metabolic advantages and vulnerabilities in brain metastases. Clinical & Experimental Metastasis 34:6-7, pages 401-410.
Crossref
Crossref
Alexander Heinzel, Dirk Müller, Sareh Said Yekta-Michael, Garry Ceccon, Karl-Josef Langen, Felix M Mottaghy, Martin Wiesmann, Martin Kocher, Elke Hattingen & Norbert Galldiks. (2017) O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis. Neuro-Oncology 19:9, pages 1271-1278.
Crossref
Crossref
Jay S. Detsky, Julia Keith, John Conklin, Sean Symons, Sten Myrehaug, Arjun Sahgal, Chinthaka C. Heyn & Hany Soliman. (2017) Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology. Journal of Neuro-Oncology 134:2, pages 433-441.
Crossref
Crossref
Arthur Gubian & Steffen K. Rosahl. (2017) Meta-Analysis on Safety and Efficacy of Microsurgical and Radiosurgical Treatment of Trigeminal Neuralgia. World Neurosurgery 103, pages 757-767.
Crossref
Crossref
A. N. Savateev, Yu. Yu. Trunin & N. A. Mazerkina. (2017) Radiotherapy and radiosurgery in treatment of craniopharyngiomas. Voprosy neirokhirurgii imeni N.N. Burdenko 81:3, pages 94.
Crossref
Crossref
Isabella Glitza Oliva, Hussein Tawbi & Michael A. Davies. (2017) Melanoma Brain Metastases. The Cancer Journal 23:1, pages 68-74.
Crossref
Crossref
Jordi Remon, Cécile Le Péchoux, Caroline Caramella, Frederic Dhermain, Guillame Louvel, Jean-Charles Soria & Benjamin Besse. (2017) Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung. Journal of Thoracic Oncology 12:1, pages e1-e3.
Crossref
Crossref
Arthur Geraud, Hao Ping Xu, Philippe Beuzeboc & Youlia M. Kirova. (2016) Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer. Journal of Neuro-Oncology 131:1, pages 69-72.
Crossref
Crossref